Scherm­afbeelding 2025 06 27 om 12.12.46

EUROIMMUN expands IFA portfolio for the UNIOQ 160

EUROIMMUN (part of Revvity) has added 23 new assays to its portfolio of indirect immunofluorescence assays (IFA) for use on the UNIQO 160, its all-in-one instrument for walkway IFA automation. The new assays extend existing panels for autoantibody diagnostics in rheumatology, vasculitis, hepatology and gastroenterology.

AdobeStock 592155238

Early diagnosis of iron deficiency and iron deficiency anemia with re-evaluated ferritin cut-off concentrations

Iron deficiency and iron deficiency anemia are remarkably common worldwide. However, recommended ferritin cut-off concentrations can vary widely and there is room for improvement in standardization across different assay platforms. Dr Katie Troike and Dr Adam McShane (Department of Pathology and Laboratory Medicine, Cleveland Clinic, Cleveland, OH, USA) recently conducted their own re-evaluation of ferritin […]

Urine UDS100 flash 4 1

DIASYS | Respons UDS 100

High performance solution for advanced urine determination

Scherm­afbeelding 2025 06 26 om 10.50.38

WERFEN | HIT Testing in Minutes.

The on-demand solution that saves more than time.

Scherm­afbeelding 2025 06 26 om 10.20.10

Nova biomedical | Advanced Test Menu for Critical Care

The Modern Critical Care Profile Prime Plus provides the most clinical value of any blood gas/critical care analyzer by adding essential tests for kidney function (BUN, Creatinine, eGFR), plasma volume (ePV), ionized magnesium (iMg) and MCHC.

AdobeStock 1535491428

The evolving paradigm of delayed cerebral ischemia

A comprehensive review of diagnostic and monitoring strategies Delayed cerebral ischemia following aneurysmal subarachnoid hemorrhage is a multifactorial syndrome extending beyond large-vessel vasospasm. This review explores the evolving diagnostic and monitoring landscape, emphasizing a shift toward multimodal monitoring techniques that detect microcirculatory failure, spreading depolarizations, and metabolic distress.

AdobeStock 780465909

Minimal residual disease assessment in B-cell precursor acute lymphoblastic leukemia

Assessment of minimal residual disease during B-cell precursor acute lymphoblastic leukemia provides a good indication of therapy response and prognosis. This investigation can be done in several ways, including flow cytometry. Techniques in this field have developed in recent years and CLI chatted to Dr van der Velden (Department of Immunology, Erasmus University Medical Center, […]

tumor diagnostics

AI model detects more than 170 types of cancer with remarkable precision

Researchers at Charité – Universitätsmedizin Berlin have developed crossNN, an artificial intelligence model that can classify more than 170 cancer types using DNA methylation patterns. The system achieves 99.1% precision for brain tumours and 97.8% for pan-cancer classification, working across multiple sequencing platforms including nanopore technology.

droplet on demand

Researchers develop precision droplet-on-demand system for microfluidics

A new pressure-driven method for generating individual droplets at microfluidic T-junctions offers precise temporal control over droplet formation. The technique, validated through theoretical modelling and experimental testing, promises to advance lab-on-a-chip technologies for chemical analysis, diagnostics, and biological research applications.

AdobeStock 37033405

Revvity breaks new ground with FDA-approved reference standards for precision oncology

Cancer diagnostics laboratories have gained a powerful new tool in the fight against genomic complexity. Revvity has unveiled its first FDA-compliant IVD Mimix reference standards, engineered to revolutionise quality control in next-generation sequencing and droplet digital PCR workflows for oncology applications.